ST Pharm Co Ltd (237690)

Currency in KRW
71,700
-1,200(-1.65%)
Closed·
Advertisement
237690 is included in our AI-picked strategies. See how they work
Fair Value
Day's Range
71,50075,000
52 wk Range
68,900172,100
Key Statistics
Bid/Ask
72,200.00 / 72,400.00
Prev. Close
71,700
Open
73,600
Day's Range
71,500-75,000
52 wk Range
68,900-172,100
Volume
113.66K
Average Volume (3m)
136.38K
1-Year Change
-29.7059%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
237690 Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Price Target
143,000
Upside
+99.44%
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Strong Sell
Moving Averages
Strong Sell

Analyst Ratings

10 Buy
0 Hold
0 Sell
Ratings:
10 analysts
Overall Consensus
Strong Buy

Analysts 12-Month Price Target:

Average 143,000
(+99.44% Upside)

Earnings

Latest Release
26/10/2026
EPS / Forecast
-- / --
Revenue / Forecast
97.6B / 99.33B
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 3,718
Dividend Yield
0.69%
Industry Median 1.29%
Annualised payout
500.00
Paid annually
5-Years Growth
-
Growth Streak

Compare 237690 to Peers and Sector

Metrics to compare
237690
Peers
Sector
Relationship
P/E Ratio
19.8x7.2x−0.2x
PEG Ratio
0.170.040.00
Price/Book
2.4x0.8x2.6x
Price / LTM Sales
3.9x0.7x2.8x
Upside (Analyst Target)
99.4%48.4%63.4%
Fair Value Upside
Unlock26.9%9.5%Unlock

ST Pharm Co.,Ltd., provides manufacturing services for active pharmaceutical ingredient and intermediate. The company offers small molecule and generics, an ingredient for treating viral infections; oligonucleotide based products, such as siRNA/microRNA, antisense, aptamer, decoys, and other novel oligos; monomer; and mRNA for vaccines and therapeutics. It also offers pre-clinical and bioanalytical research and development solutions. The company was formerly known as Samchully Pharmaceutical Company., Ltd. ST Pharm Co. Ltd. was founded in 1983 and is headquartered in Siheung-si, South Korea.

Employees
655

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
1.69M8.09%123.10B
Other Institutional Investors
8.77M42.02%639.44B
Public Companies & Retail Investors
10.42M49.90%759.37B
Total
20.88M100.00%1.52T

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Dong-A Pharmaceutical Co.,Ltd.29.20%6,096,552444,438,641
The National Pension Fund5.77%1,204,51187,808,852

People Also Watch

251,000
214450
+1.41%
23,900
086450
-3.63%
24,200
294870
+1.47%
7,130
137310
+0.71%
36,850
005290
+1.24%

FAQ

What Is the ST Pharm (KOSDAQ: 237690) Share Price Today?

The ST Pharm stock price today is 71,700 KRW.

What Stock Exchange Does ST Pharm (237690) Trade On?

ST Pharm is listed and trades on the KOSDAQ.

What Is the Ticker (Stock Symbol) for ST Pharm?

The stock symbol (also called a 'ticker') for ST Pharm is "237690."

Does ST Pharm Pay Dividends? What’s The Current 237690 Dividend Yield?

Yes, 237690 Pays Dividends to its Shareholders. The current ST Pharm dividend yield is 0.7%%.

What Is the Current ST Pharm Market Capitalisation?

As of today, ST Pharm (KOSDAQ: 237690) market cap is 1.52T KRW.

What Is ST Pharm's (237690) Earnings Per Share (TTM)?

The ST Pharm EPS is currently 3,718 (Trailing Twelve Months).

When Is the Next ST Pharm Earnings Date?

ST Pharm's next earnings report will be released on 15/02/2027.

Is 237690 a Buy or Sell From a Technical Analyst Perspective?

Based on today's ST Pharm moving averages and other technical indicators, the daily buy/sell signal for 237690 stock is Strong Sell.

How Many Times Has ST Pharm Stock Split?

ST Pharm has split 0 times. (See the 237690 stock split history page for full effective split date and price information.)

How Many Employees Does ST Pharm Have?

ST Pharm has 655 employees, based on their latest Companies House report.

What is the current trading status of ST Pharm (KOSDAQ: 237690)?

As of 13/11/2026, ST Pharm (237690) is trading at a share price of 71,700 KRW, with a previous close of 71,700 KRW. The stock has fluctuated within a day range of 71,500 KRW to 75,000 KRW, while its 52-week range spans from 68,900 KRW to 172,100 KRW.

What Is ST Pharm (237690) Price Target According to Analysts?

The average 12-month price target for ST Pharm is 143,000 KRW, with a high estimate of 180000 KRW and a low estimate of 100000 KRW. 10 analysts recommend buying the stock, while 0 suggest selling, leading to an overall rating of Strong Buy. The stock has an +99.44% Upside potential.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.